Literature DB >> 4008994

Instability of antibiotic resistance in a strain of Staphylococcus epidermidis isolated from an outbreak of prosthetic valve endocarditis.

P A Mickelsen, J J Plorde, K P Gordon, C Hargiss, J McClure, F D Schoenknecht, F Condie, F C Tenover, L S Tompkins.   

Abstract

Plasmid profiles, phage typing, antibiograms, and biotyping were used to characterize Staphylococcus epidermidis isolated from multiple cultures of blood of four patients with prosthetic valve endocarditis. Epidemiological evidence implicated a common source for these infections. Of 20 clinically significant isolates, 14 exhibited variations from the prototype pattern of multiple resistance to five antibiotics. All isolates tested appeared to be the same strain by phage typing. Of 18 isolates available for plasmid analysis, 10 contained six plasmids of identical size, whereas eight differed from the prototype profile in the loss of one to three plasmids. Loss of resistance to gentamicin, chloramphenicol, erythromycin, and clindamycin but not to methicillin was associated with the loss of specific plasmids. Because antibiotic resistance in this strain of S. epidermidis was unstable, the use of antibiograms alone was not a reliable means of evaluating the relatedness of these multiple isolates.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4008994     DOI: 10.1093/infdis/152.1.50

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Comparative evaluation of a new molecular method for typing Staphylococcus epidermidis.

Authors:  J Wilton; K Jung; I Vedin; B Aronsson; J I Flock
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

2.  Typing of coagulase-negative staphylococci by Southern hybridization of chromosomal DNA fingerprints using a ribosomal RNA probe.

Authors:  H Bialkowska-Hobrzanska; V Harry; D Jaskot; O Hammerberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-08       Impact factor: 3.267

3.  Characterization of clinically significant isolates of Staphylococcus epidermidis from patients with endocarditis.

Authors:  J Etienne; Y Brun; N el Solh; V Delorme; C Mouren; M Bes; J Fleurette
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

4.  Molecular relatedness of Staphylococcus epidermidis isolates obtained during a platelet transfusion-associated episode of sepsis.

Authors:  M Shayegani; L M Parsons; A L Waring; J Donhowe; R Goering; W A Archinal; J Linden
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

5.  Use of cleaved amplified polymorphic sequences to distinguish strains of Staphylococcus epidermidis.

Authors:  S B Calderwood; M A Baker; P A Carroll; J L Michel; R D Arbeit; F M Ausubel
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

Review 6.  Antimicrobial resistance of Staphylococcus aureus: genetic basis.

Authors:  B R Lyon; R Skurray
Journal:  Microbiol Rev       Date:  1987-03

7.  Prevalence of peritonitis-associated coagulase-negative staphylococci on the skin of continuous ambulatory peritoneal dialysis patients.

Authors:  M A Beard-Pegler; C L Gabelish; E Stubbs; C Harbour; J Robson; M Falk; R Benn; A Vickery
Journal:  Epidemiol Infect       Date:  1989-06       Impact factor: 2.451

Review 8.  Current problems of chemotherapy of infections with coagulase-negative staphylococci.

Authors:  A J Davies; J W Stone
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

9.  Epidemiological fingerprinting of Enterobacter cloacae by small-fragment restriction endonuclease analysis and pulsed-field gel electrophoresis of genomic restriction fragments.

Authors:  R Haertl; G Bandlow
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

10.  Oral infections and septicemia in immunocompromised patients with hematologic malignancies.

Authors:  O J Bergmann
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.